Public Health
RCT: A comprehensive geriatric assessment hospital at home may be a cost-effective alternative to hospital admission.
1 Feb, 2022 | 08:32h | UTC
During the COVID-19 pandemic, female, primary care, and behavioral health physicians were most likely to be early adopters of virtual health care. Physicians born between 1928 and 1945 and in surgical specialties were less likely to be early adopters.
28 Jan, 2022 | 08:20h | UTC
Impact of the COVID‐19 pandemic on pediatric oncology providers globally: A mixed‐methods study.
27 Jan, 2022 | 09:46h | UTCNews Release: How has the COVID-19 pandemic impacted clinicians who care for children with cancer? – Wiley
RCT: Electronic directly observed therapy is noninferior to in-person observed therapy for ensuring adherence to tuberculosis treatment.
26 Jan, 2022 | 01:58h | UTC
Commentary on Twitter
In this 2-year study, data showed that electronic directly observed therapy (eDOT) was as effective as traditional in-person DOT for ensuring high adherence to treatment of tuberculosis disease. @CDC_TB @nycHealthy @ColumbiaMed https://t.co/yTrU1JRuwn pic.twitter.com/QXthE4d266
— JAMA Network Open (@JAMANetworkOpen) January 20, 2022
Guidelines on Screen Time and Digital Wellness in Infants, Children and Adolescents – “children below 2 years age should not be exposed to any type of screen, whereas exposure should be limited to a maximum of one hour of supervised screen time per day for children 24-59 months age, and less than two hours per day for children 5-10 years age”.
25 Jan, 2022 | 09:30h | UTCRelated Guideline: Media and Young Minds – American Academy of Pediatrics
Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study.
25 Jan, 2022 | 09:13h | UTC
Commentary on Twitter
A new study using data from the #GBD 2019 study estimated trends in congenital #heartdisease (CHD) mortality in 204 countries and territories over the past 30 years.
Read more here: https://t.co/6NtW0TYMAG pic.twitter.com/VLCU9OuOwx
— eClinicalMedicine – The Lancet Discovery Science (@eClinicalMed) January 14, 2022
No amount of alcohol is good for the heart, says World Heart Federation.
24 Jan, 2022 | 08:23h | UTCNews Release: No amount of alcohol is good for the heart, says World Heart Federation
Commentary: No amount of alcohol is good for the heart, new report says, but critics disagree on science – CNN
Review: Health literacy interventions for secondary prevention of coronary artery disease.
24 Jan, 2022 | 08:12h | UTC
Is precision public health the future — or a contradiction?
21 Jan, 2022 | 09:31h | UTCIs precision public health the future — or a contradiction? – Nature
Cluster Randomized Trial: A multifactorial falls prevention program in UK care homes reduced fall rates among older people and was cost effective.
21 Jan, 2022 | 09:21h | UTCNews Release: Falls in care homes can be significantly reduced with intervention, says new study – University of Nottingham
Commentary on Twitter
NEW RESEARCH: A falls prevention programme for older people in care homes, co-designed with care home staff & residents, that involved awareness raising, education, screening, decision & implementation support was associated with a reduction in falls rate https://t.co/wupI0LeAxj
— The BMJ (@bmj_latest) December 11, 2021
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
20 Jan, 2022 | 09:17h | UTCGlobal burden of bacterial antimicrobial resistance in 2019: a systematic analysis – The Lancet
Editorial: Antimicrobial resistance: time to repurpose the Global Fund – The Lancet
Commentary: Antimicrobial resistance now a leading cause of death worldwide, study finds – The Guardian
Commentary on Twitter
NEW—An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections, more deaths than HIV/AIDS or malaria.#GRAMPaper reveals the scale of antimicrobial resistance (#AMR), now a leading cause of death worldwide: https://t.co/2h5UEKemEq #AMRSOS pic.twitter.com/aWLhmdirJ8
— The Lancet (@TheLancet) January 20, 2022
1.8 million excess deaths attributable to urban air pollution in 2019, modelling study suggests.
20 Jan, 2022 | 09:13h | UTCNews Release: The Lancet Planetary Health: 1.8 million excess deaths attributable to urban air pollution in 2019, modelling study suggests
Related Studies:
Commentary on Twitter (thread – click for more)
NEW—Approx. 86% of people living in urban areas exposed to unhealthy particulate matter levels, leading to 1.8 million excess deaths in 2019: modelling study in @TheLancetPlanet. #AirPollutionhttps://t.co/kw34ANZ4ph
Thread ? pic.twitter.com/QiRXU4QVHP
— The Lancet (@TheLancet) January 6, 2022
Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study.
18 Jan, 2022 | 09:27h | UTC
Grand Challenges in global eye health: a global prioritization process using Delphi method.
18 Jan, 2022 | 09:15h | UTCRelated podcast: Author interview
Commentary on Twitter
Roughly 2.2 billion people have vision impairment—yet 50% of sight loss is preventable.
In @LancetLongevity, Jacqueline Ramke & colleagues identify the key issues that must be addressed to improve global #EyeHealth in the context of an ageing population.https://t.co/banTov24VX pic.twitter.com/tLSZaUYXhw
— The Lancet (@TheLancet) January 6, 2022
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.
13 Jan, 2022 | 08:42h | UTCInvited Commentary: The true global disease burden of mental illness: still elusive – The Lancet Psychiatry (free registration required)
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019.
11 Jan, 2022 | 02:38h | UTCNews Release: Global dementia cases set to triple by 2050 unless countries address risk factors – The Lancet
Commentaries:
Forecasting the prevalence of dementia – The Lancet Public Health
Dementia cases expected to almost triple across the world by 2050 – BBC
Number of adults with dementia to exceed 150m by 2050, study finds – The Guardian
Commentary on Twitter (thread – click for more)
?✨First #GBDstudy forecasts global #dementia cases set to triple by 2050 (up from 57m in 2019 to expected 153m people) unless countries address risk factors: #smoking, #obesity, #HighBloodSugar, & low #education??
Published in @TheLancet @TheLancetPHhttps://t.co/GccTPRroEV
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) January 7, 2022
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.
11 Jan, 2022 | 02:30h | UTC
New AAP Guidance recommends routine HIV screening to all youth 15 years or older.
8 Jan, 2022 | 23:13h | UTCCommentary: Pediatricians Can Play Key Role in HIV Testing, Prophylaxis – HealthDay
FDA approves first injectable treatment for HIV pre-exposure prevention.
8 Jan, 2022 | 23:04h | UTCCommentaries:
NIH celebrates FDA approval of long-acting injectable drug for HIV prevention – NIH News Releases
A new injection to prevent HIV, rather than pills, is a game-changer, scientists say – NPR
Related:
CDC Guidance: Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents
USPSTF Statement: Preexposure Prophylaxis for the Prevention of HIV Infection
British Guidelines on the Use of HIV Pre–exposure Prophylaxis (PrEP) (several guidelines on the subject)
New Protocol for HIV Prevention Drug Reduces The Number Of Pills Required
RCT: Low-cost, easy to take antiretroviral treatment based on Dolutegravir as first- or second-Line therapy found to be non-inferior to standard care for treating HIV-1 infection in children.
8 Jan, 2022 | 23:07h | UTCDolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Easy-to-take medicine better at suppressing HIV in children – University College London
Commentaries on Twitter
Dolutegravir-based antiretroviral therapy was compared with standard care in children and adolescents starting first- or second-line therapy for HIV type 1 infection. Dolutegravir-based ART was superior to standard-care ART. https://t.co/PP0XaEVswO pic.twitter.com/pQvhjdXcUk
— NEJM (@NEJM) December 29, 2021
Visual Abstract: Dolutegravir as First- or Second-Line HIV Treatment in Children https://t.co/2RIg9uH2V1 pic.twitter.com/mDr1Z6l6CJ
— NEJM (@NEJM) January 4, 2022
Abortion safety and use with normally prescribed Mifepristone in Canada.
16 Dec, 2021 | 08:51h | UTCNews Release: Prescribing the abortion pill without restrictions is safe and effective, study finds – University of British Columbia
Opinion: Decision makers need constantly updated evidence synthesis.
16 Dec, 2021 | 08:39h | UTCDecision makers need constantly updated evidence synthesis – Nature
Recommendations for equitable COVID-19 pandemic recovery in Canada.
14 Dec, 2021 | 09:47h | UTCNews Release: Equitable COVID-19 pandemic recovery in Canada: New guideline – Canadian Medical Association Journal
Editorial: Build back more equitably
WHO Reports | More than half a billion people pushed or pushed further into extreme poverty due to health care costs.
14 Dec, 2021 | 08:55h | UTCReport 1: Tracking Universal Health Coverage: 2021 Global monitoring report – World Health Organization
Report 2: Global monitoring report on financial protection in health 2021 – World Health Organization
WHO Report | Saving lives, spending less: the case for investing in noncommunicable diseases.
14 Dec, 2021 | 08:53h | UTC
Commentary on Twitter
? WHO report shows that investing only 1⃣ USD per person per year in the prevention and control of noncommunicable diseases could save almost 7⃣ million lives ? by 2030. Let's #BeatNCDs!https://t.co/KP71n5M1cY pic.twitter.com/kviaoWc2J5
— World Health Organization (WHO) (@WHO) December 13, 2021